These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4024237)

  • 21. Clinical evaluation of a 51Cr-labeled red blood cell survival test for in vivo blood compatibility testing.
    Pineda AA; Dharkar DD; Wahner HW
    Mayo Clin Proc; 1984 Jan; 59(1):25-30. PubMed ID: 6694429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the blood of an MiV/Mk proposita and her family.
    Judd WJ; Geisland JR; Issitt PD; Wilkinson SL; Anstee DJ; Shin C; Glidden H
    Transfusion; 1983; 23(1):33-6. PubMed ID: 6829056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MNSs blood group system and antibodies(anti-M, -N, -S and -S antibodies)].
    Murakami J
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():743-7. PubMed ID: 20942178
    [No Abstract]   [Full Text] [Related]  

  • 24. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival studies of 51Cr Ch(a+) red blood cells in a patient with anti-Cha, and massive transfusion of incompatible blood.
    Nordhagen R; Aas M
    Vox Sang; 1979; 37(3):179-81. PubMed ID: 494587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta.
    Davey RJ; Simpkins SS
    Transfusion; 1981; 21(6):702-5. PubMed ID: 7314218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the in vivo elution of 51Cr from baboon red blood cells.
    Valeri CR; Kuehl GV; Skrabut EM; Bechthold DA; Vecchione JJ; Harkness DR; Emerson CP
    Vox Sang; 1981 May; 40(5):338-45. PubMed ID: 7245719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MNSs blood group system and antibodies (anti-M, -N, -S and -S antibodies)].
    Murakami J
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():680-3. PubMed ID: 16111366
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-JMH identified in serum and in eluate from red cells of a JMH-negative man.
    Whitsett CF; Moulds M; Pierce JA; Hare V
    Transfusion; 1983; 23(4):344-5. PubMed ID: 6410552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Jka, -C, and -E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr-labeled red cell studies.
    Maynard BA; Smith DS; Farrar RP; Kraetsch RE; Chaplin H
    Transfusion; 1988; 28(4):302-6. PubMed ID: 3133842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
    Vichinsky EP; Luban NL; Wright E; Olivieri N; Driscoll C; Pegelow CH; Adams RJ;
    Transfusion; 2001 Sep; 41(9):1086-92. PubMed ID: 11552063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report of transfusions of M- and P1-positive red cells to a patient with anti-M and anti-P1.
    Aubuchon JP; Anderson HJ; Van Nguyen D
    Transfusion; 1985; 25(2):181-2. PubMed ID: 3984018
    [No Abstract]   [Full Text] [Related]  

  • 34. Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red-cell serology with investigations of chromium-51-labelled red-cell kinetics.
    Panzer S; Püchler K; Mayr WR; Höcker P; Graninger W; Lechner K
    Lancet; 1987 Feb; 1(8531):474-8. PubMed ID: 2881040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed overt hemolytic transfusion reaction due to anti-U antibody.
    Rothman IK; Alter HJ; Strewler GJ
    Transfusion; 1976; 16(4):357-60. PubMed ID: 951732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test.
    Kickler TS; Smith B; Bell W; Drew H; Baldwin M; Ness PM
    Transfusion; 1985; 25(5):401-5. PubMed ID: 4049483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.
    King KE; Shirey RS; Lankiewicz MW; Young-Ramsaran J; Ness PM
    Transfusion; 1997 Apr; 37(4):376-81. PubMed ID: 9111274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR.
    McCurdy PR; Sherman AS
    Am J Med; 1978 Feb; 64(2):253-8. PubMed ID: 629275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-M after transfusion as an indication of a genetic variant of the MN locus].
    Heuft HG; Weisbach V; Zeiler T; Zimmermann R; Zingsem J; Eckstein R
    Beitr Infusionsther; 1992; 30():391-4. PubMed ID: 1284743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.